AG
NVO

AlTi Global’s Novo Nordisk NVO Stock Holding History

AlTi Global’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
6,590
+255
+4% +$11K 0.01% 422
2026
Q1 		$241K Sell
6,335
-2,609
-29% -$124K 0.01% 397
2025
Q4 		$455K Buy
8,944
+291
+3% +$14.9K 0.01% 318
2025
Q3 		$480K Sell
8,653
-1,995
-19% -$117K 0.01% 317
2025
Q2 		$735K Buy
10,648
+5,059
+91% +$344K 0.02% 268
2025
Q1 		$394K Sell
5,589
-199
-3% -$16.4K 0.01% 298
2024
Q4 		$498K Hold
5,788
– – 0.01% 281
2024
Q3 		$689K Buy
5,788
+141
+2% +$18.8K 0.02% 242
2024
Q2 		$806K Buy
5,647
+1,318
+30% +$175K 0.02% 224
2024
Q1 		$560K Buy
4,329
+15
+0.3% +$1.79K 0.02% 236
2023
Q4 		$446K Buy
+4,314
New +$427K 0.01% 252

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AlTi Global's NVO Position: Q2 2026 in Review

AlTi Global increased its Novo Nordisk (NVO) stake by 4% in Q2 2026, buying an estimated $11K and bringing the position to 6,590 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #422.

AlTi Global first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $806K in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • AlTi Global held 6,590 shares of Novo Nordisk worth $316K as of Q2 2026.
  • AlTi Global bought 255 Novo Nordisk shares in Q2 2026, an estimated $11K.
  • Novo Nordisk made up 0.01% of AlTi Global's portfolio in Q2 2026, its #422 holding.
  • AlTi Global first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Novo Nordisk position peaked at $806K in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.